Katelin B. Krause v. HHS - HPV, transverse myelitis (2020)
Case summary [AI summaries can sometimes make mistakes]
Katelin B. Krause, formerly Katelin Arnold, filed a petition on June 13, 2013, alleging that she developed transverse myelitis after receiving human papillomavirus (HPV), hepatitis A, hepatitis B, and influenza vaccinations.
The respondent denied that these vaccinations caused the petitioner's injury. After several years of litigation, the parties filed a joint stipulation on March 24, 2020, agreeing to settle the case.
Special Master Mindy Michaels Roth reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. As part of the settlement, the respondent agreed to issue a lump sum payment of $50,000.00, payable to Katelin Krause, as compensation for all damages available under 42 U.S.C. § 300aa-15(a).
The public decision does not describe the petitioner's specific clinical story, onset of symptoms, diagnostic tests, treatments, or the specific mechanism of causation. Petitioner was represented by Robert Krakow, Esq., of the Law Office of Robert J.
Krakow, and respondent was represented by Debra Begley, Esq., of the US Department of Justice.
Theory of causation
Petitioner alleged that HPV, Hepatitis A, Hepatitis B, and Influenza vaccines caused her to develop transverse myelitis. The parties reached a joint stipulation on March 24, 2020, to settle the case. Special Master Mindy Michaels Roth adopted the stipulation. Petitioner was awarded $50,000.00 as a lump sum. Petitioner was represented by Robert Krakow, Esq., and respondent by Debra Begley, Esq. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury.
Source PDFs
USCOURTS-cofc-1_13-vv-00395